Acadia Pharmaceuticals Ownership & Insider Activity

Acadia Pharmaceuticals Inc

ACADNASDAQ

$20.17

0.432.18%

Dern. MÀJ: Oct 28, 8:06 AM

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financières SentimentActionnariatComparer Options Rapport sur les stocks

Résultats: Résultats Q3 2026 dans dans 7 jours à partir de maintenant le mer. nov. 4th, après la fermeture du marché

Conférence téléphonique: Conférence téléphonique prévue dans 7 jours à 4:30 PM

Cliquez pour voir la webdiffusion

Acadia Pharmaceuticals Ownership & Insider Activity

Acadia Pharmaceuticals (ACAD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.7% of shares outstanding. Institutional investors hold 44.2%.

Shares Outstanding

171.215M

Shares Float

107.941M

Insider Shares Owned

1.236M

Insider % Owned

0.7%

Institutional Shares Held

76.106M

Institutional % Held

44.2%

Ownership Breakdown

Net Insider Activity by Month

Acadia Pharmaceuticals Insider Transactions (Last 6 Months)

Voir toutes les transactions d'initiés →

Date	Insider	Title	Type	Shares	Price	Value
Aug 5, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$23.50	$228K
Jul 29, 2026	HZ Elizabeth Thompson	EVP, HEAD RESEARCH & DEV	SELL-OPTIONS	15.714K	$26.13	$433K
Jun 26, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL	11.421K	$26.08	$298K
May 26, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL	5.401K	$21.18	$114K
May 1, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL-OPTIONS	1.264K	$21.79	$29K
May 1, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	3.309K	$21.79	$76K

Congressional Trading Activity

Voir toutes les transactions gouvernementales →

Date	Member	Party	Chamber	Action	Amount
Jun 16, 2022	Chris Jacobs	R	House	Sale	$1,001 - $15,000

Acadia Pharmaceuticals Ownership & Insider Activity

Acadia Pharmaceuticals (ACAD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.7% of shares outstanding. Institutional investors hold 44.2%.

Shares Outstanding

171.215M

Shares Float

107.941M

Insider Shares Owned

1.236M

Insider % Owned

0.7%

Institutional Shares Held

76.106M

Institutional % Held

44.2%

Ownership Breakdown

Net Insider Activity by Month

Acadia Pharmaceuticals Insider Transactions (Last 6 Months)

Voir toutes les transactions d'initiés →

Date	Insider	Title	Type	Shares	Price	Value
Aug 5, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$23.50	$228K
Jul 29, 2026	HZ Elizabeth Thompson	EVP, HEAD RESEARCH & DEV	SELL-OPTIONS	15.714K	$26.13	$433K
Jun 26, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL	11.421K	$26.08	$298K
May 26, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL	5.401K	$21.18	$114K
May 1, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL-OPTIONS	1.264K	$21.79	$29K
May 1, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	3.309K	$21.79	$76K

Congressional Trading Activity

Voir toutes les transactions gouvernementales →

Date	Member	Party	Chamber	Action	Amount
Jun 16, 2022	Chris Jacobs	R	House	Sale	$1,001 - $15,000

Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Ownership & Insider Activity

Acadia Pharmaceuticals Insider Transactions (Last 6 Months)

Congressional Trading Activity

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Acadia Pharmaceuticals Ownership & Insider Activity

Acadia Pharmaceuticals Insider Transactions (Last 6 Months)

Congressional Trading Activity

People Also Watch

People Also Watch